Paper17517843
Experimental phage therapy against Staphylococcus aureus in mice.
Capparelli R and 4 others. Antimicrob Agents Chemother, 2007. Cited by 228 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Experimental phage therapy against Staphylococcus aureus in mice. Papers, record 17517843. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517843
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Staphylococcal Infections | Major topic |
| Staphylococcus Phages | Major topic |
| Staphylococcus aureus | Major topic |
| Animals | |
| Colony Count, Microbial | |
| Female | |
| Humans | |
| Macrophages, Peritoneal | |
| Methicillin Resistance | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,728,933 | Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15728933 | PubMed |
| 2 | 15,577,930 | Antibacterial resistance worldwide: causes, challenges and responses. | Nat Med | 2004 | https://conductscience.org/library/papers/15577930 | PubMed |
| 3 | 16,204,526 | Detection and characterization of Streptococcus thermophilus bacteriophages by use of the antireceptor gene sequence. | Appl Environ Microbiol | 2005 | https://conductscience.org/library/papers/16204526 | PubMed |
| 4 | 16,322,743 | Immune evasion by staphylococci. | Nat Rev Microbiol | 2005 | https://conductscience.org/library/papers/16322743 | PubMed |
| 5 | 16,306,938 | An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. | Nature | 2006 | https://conductscience.org/library/papers/16306938 | PubMed |
| 6 | 16,451,412 | Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. | Clin Microbiol Infect | 2006 | https://conductscience.org/library/papers/16451412 | PubMed |
| 7 | 16,778,840 | Non-inherited antibiotic resistance. | Nat Rev Microbiol | 2006 | https://conductscience.org/library/papers/16778840 | PubMed |
| 8 | 17,015,317 | Pharmacodynamics of non-replicating viruses, bacteriocins and lysins. | Proc Biol Sci | 2006 | https://conductscience.org/library/papers/17015317 | PubMed |
| 9 | 10,698,991 | Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. | J Clin Microbiol | 2000 | https://conductscience.org/library/papers/10698991 | PubMed |
| 10 | 11,014,403 | Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. | Clin Pharmacol Ther | 2000 | https://conductscience.org/library/papers/11014403 | PubMed |
| 11 | 11,181,338 | Bacteriophage therapy. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11181338 | PubMed |
| 12 | 11,302,801 | In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11302801 | PubMed |
| 13 | 11,352,067 | Why we don't get sick: the within-host population dynamics of bacterial infections. | Science | 2001 | https://conductscience.org/library/papers/11352067 | PubMed |
| 14 | 11,526,172 | Multiplex PCR protocol for the diagnosis of staphylococcal infection. | J Clin Microbiol | 2001 | https://conductscience.org/library/papers/11526172 | PubMed |
| 15 | 11,748,184 | Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. | Infect Immun | 2002 | https://conductscience.org/library/papers/11748184 | PubMed |
| 16 | 11,796,592 | Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. | Infect Immun | 2002 | https://conductscience.org/library/papers/11796592 | PubMed |
| 17 | 12,355,367 | Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. | J Infect Dis | 2002 | https://conductscience.org/library/papers/12355367 | PubMed |
| 18 | 12,379,713 | Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. | Infect Immun | 2002 | https://conductscience.org/library/papers/12379713 | PubMed |
| 19 | 12,453,306 | Dynamics of success and failure in phage and antibiotic therapy in experimental infections. | BMC Microbiol | 2002 | https://conductscience.org/library/papers/12453306 | PubMed |
| 20 | 12,599,078 | Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. | J Infect Dis | 2003 | https://conductscience.org/library/papers/12599078 | PubMed |
Cited by135
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,515,603 | Isolation, Characterization, and In Vivo Evaluation Efficacy of Lytic Bacteriophage SEP1 Against Salmonella Paratyphi C. | Viruses | 2026 | https://conductscience.org/library/papers/42515603 | PubMed |
| 42,505,596 | Effect of Bacteriophage Administration Route on Phage Localization in a Rat MRSA Implant-Associated Infection Model. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42505596 | PubMed |
| 42,488,416 | Bacteriophage therapy beyond antibiotics: emerging innovations for infectious and non-infectious diseases. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42488416 | PubMed |
| 41,762,342 | A comprehensive analysis of the kinetics of infection of lytic bacteriophages specific to the ESKAPE and critical pathogens. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/41762342 | PubMed |
| 41,753,631 | Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus. | Microorganisms | 2026 | https://conductscience.org/library/papers/41753631 | PubMed |
| 41,746,166 | Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. | Infect Immun | 2026 | https://conductscience.org/library/papers/41746166 | PubMed |
| 41,728,112 | Bacterial meningitis in adults: therapeutic challenges in the era of antibiotic resistance and the potential of bacteriophages and associated by products. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41728112 | PubMed |
| 41,681,534 | Phage Therapy in Plant Disease Management: 110 Years of History, Current Challenges, and Future Trends. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/41681534 | PubMed |
| 41,279,710 | Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279710 | PubMed |
| 40,981,439 | Comparative antibacterial activity of N-terminal and C-terminal domains of a recombinant endolysin against Cutibacterium acnes. | Appl Environ Microbiol | 2025 | https://conductscience.org/library/papers/40981439 | PubMed |
| 40,838,049 | Design of respirable sprayed microparticles of encapsulated bacteriophages. | Front Drug Deliv | 2023 | https://conductscience.org/library/papers/40838049 | PubMed |
| 40,470,315 | Deep learning-guided structural analysis of a novel bacteriophage KPP105 against multidrug-resistant Klebsiella pneumoniae. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/40470315 | PubMed |
| 40,256,450 | Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheep. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40256450 | PubMed |
| 40,176,987 | Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40176987 | PubMed |
| 40,045,940 | Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy. | Phage (New Rochelle) | 2024 | https://conductscience.org/library/papers/40045940 | PubMed |
| 39,699,213 | In vitro resensitization of multidrug-resistant clinical isolates of Enterococcus faecium and E. faecalis through phage-antibiotic synergy. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/39699213 | PubMed |
| 38,935,199 | A novel Enterococcus faecalis bacteriophage Ef212: biological and genomic features. | Int Microbiol | 2025 | https://conductscience.org/library/papers/38935199 | PubMed |
| 38,659,581 | Phage-antibiotic combinations in various treatment modalities to manage MRSA infections. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38659581 | PubMed |
| 38,378,698 | Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo. | Nat Commun | 2024 | https://conductscience.org/library/papers/38378698 | PubMed |
| 37,679,422 | The stability of Staphylococcal bacteriophage in presence of local vancomycin concentrations used in clinical practice. | Eur J Orthop Surg Traumatol | 2024 | https://conductscience.org/library/papers/37679422 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17517843
GET https://conductscience.org/api/papers/v1/17517843/references?page=2